直肠给药的泼尼松龙——主要为局部作用的证据。
Rectally administered prednisolone--evidence for a predominantly local action.
作者信息
Lee D A, Taylor M, James V H, Walker G
出版信息
Gut. 1980 Mar;21(3):215-8. doi: 10.1136/gut.21.3.215.
Abstract
Plasma prednisolone levels have been compared in healthy volunteers and in patients suffering from idiopathic proctocolitis after the administration of standard retention enemata containing either prednisolone-21-phosphate or prednisolone metasulphobenzoate sodium. The levels were significantly lower after the latter, irrespective of the presence or degree of activity of the disease. Prednisolone metasulphobenzoate appeared to be as effective as the 21-phosphate ester for the treatment of proctocolitis in the few patients where the two drugs were compared. It seems possible that the beneficial effect of the form of therapy is exerted predominantly locally, rather than by systemic action.
摘要
对健康志愿者以及患有特发性直肠结肠炎的患者，在给予含有磷酸泼尼松龙或甲磺苯甲酸钠泼尼松龙的标准保留灌肠剂后，比较了血浆泼尼松龙水平。无论疾病是否存在或活动程度如何，使用后者后血浆泼尼松龙水平显著较低。在少数比较了这两种药物的患者中，甲磺苯甲酸钠泼尼松龙治疗直肠结肠炎的效果似乎与21 - 磷酸酯一样有效。治疗形式的有益作用似乎主要是在局部发挥，而非通过全身作用。
相似文献
1
Rectally administered prednisolone--evidence for a predominantly local action.直肠给药的泼尼松龙——主要为局部作用的证据。
Gut. 1980 Mar;21(3):215-8. doi: 10.1136/gut.21.3.215.
2
Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema.给予磷酸泼尼松龙21作为保留灌肠剂后血浆泼尼松龙水平和肾上腺皮质反应性。
Gut. 1979 May;20(5):349-55. doi: 10.1136/gut.20.5.349.
3
Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis.在结肠炎患者中，以磷酸泼尼松龙21-磷酸酯作为保留灌肠剂给药后血浆泼尼松龙水平。
Br Med J. 1976 Jan 24;1(6003):193-5. doi: 10.1136/bmj.1.6003.193.
4
Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis.吸收不佳的泼尼松龙灌肠剂对远端结肠炎的治疗益处。
Gut. 1985 Aug;26(8):822-4. doi: 10.1136/gut.26.8.822.
5
6
A comparison of prednisolone enemas with low-dose oral prednisolone in the treatment of acute distal ulcerative colitis.泼尼松龙灌肠剂与小剂量口服泼尼松龙治疗急性远端溃疡性结肠炎的比较。
Dis Colon Rectum. 1984 Nov;27(11):701-2. doi: 10.1007/BF02554591.
7
8
[Posterior subcapsular cataract in a case of ulcerative colitis treated with corticosteroid enema].[溃疡性结肠炎患者使用皮质类固醇灌肠治疗后出现后囊下白内障]
J Fr Ophtalmol. 2003 Oct;26(8):834-6.
9
[Treatment of proctocolitis with prednisolone enemas].[泼尼松龙灌肠治疗直肠结肠炎]
Munch Med Wochenschr. 1962 May 11;104:897-900.
10
A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis.用于活动性直肠结肠炎的口服泼尼松龙单剂量与每日多次剂量的比较。
Scand J Gastroenterol. 1978;13(7):833-7. doi: 10.3109/00365527809182199.
引用本文的文献
1
Urinary excretion profile of prednisolone and prednisone after rectal administration: Significance in antidoping analysis.直肠给予后泼尼松龙和泼尼松的尿排泄谱：在反兴奋剂分析中的意义。
Drug Test Anal. 2022 Nov;14(11-12):2007-2016. doi: 10.1002/dta.3352. Epub 2022 Aug 12.
2
Advances in colonic drug delivery.结肠给药的进展。
Drugs. 2005;65(14):1991-2007. doi: 10.2165/00003495-200565140-00006.
3
Inflammatory bowel disease management. Some thoughts on future drug developments.炎症性肠病的管理。关于未来药物研发的一些思考。
Drugs. 1997 Feb;53(2):189-94. doi: 10.2165/00003495-199753020-00001.
4
Toward optimal use of corticosteroids in ulcerative colitis and Crohn's disease.实现溃疡性结肠炎和克罗恩病中皮质类固醇的最佳使用。
Gut. 1983 Mar;24(3):177-81. doi: 10.1136/gut.24.3.177.
5
Medical treatment of ulcerative colitis.溃疡性结肠炎的医学治疗。
Postgrad Med J. 1984 Nov;60(709):797-802. doi: 10.1136/pgmj.60.709.797.
6
Rectal drug administration: clinical pharmacokinetic considerations.直肠给药：临床药代动力学考量
Clin Pharmacokinet. 1982 Jul-Aug;7(4):285-311. doi: 10.2165/00003088-198207040-00002.
7
Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion.溃疡性结肠炎患者局部应用5-氨基水杨酸灌肠剂。直肠吸收与排泄的研究。
Gut. 1985 Apr;26(4):400-5. doi: 10.1136/gut.26.4.400.
8
Therapeutic benefits from a poorly absorbed prednisolone enema in distal colitis.吸收不佳的泼尼松龙灌肠剂对远端结肠炎的治疗益处。
Gut. 1985 Aug;26(8):822-4. doi: 10.1136/gut.26.8.822.
9
Comparative trial of sodium cromoglycate enemas with prednisolone enemas in the treatment of ulcerative colitis.色甘酸钠灌肠剂与泼尼松龙灌肠剂治疗溃疡性结肠炎的对比试验
Gut. 1987 Jan;28(1):88-92. doi: 10.1136/gut.28.1.88.
10
Inflammatory bowel disease.炎症性肠病
CMAJ. 1989 Jul 15;141(2):113-23; discussion 123-4.
本文引用的文献
1
Rectal absorption of radioactive 6-alpha-methyl prednisolone in ulcerative colitis.放射性6-α-甲基泼尼松龙在溃疡性结肠炎中的直肠吸收情况。
J Med Liban. 1961;14:380-6.
2
URINARY EXCRETION OF PREDNISOLONE AFTER INTRARECTAL THERAPY IN ULCERATIVE COLITIS.溃疡性结肠炎直肠内治疗后泼尼松龙的尿排泄情况
Br Med J. 1964 Oct 24;2(5416):1045-6. doi: 10.1136/bmj.2.5416.1045.
3
VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS.观察者在描述直肠炎黏膜外观时的差异。
Br Med J. 1964 Jan 11;1(5375):89-92. doi: 10.1136/bmj.1.5375.89.
4
Absorption of hydrocortisone from the large bowel.氢化可的松从大肠的吸收。
Lancet. 1963 Mar 30;1(7283):701-2. doi: 10.1016/s0140-6736(63)91453-3.
5
Rectal absorption of 6alpha-(C-14)-methylprednisolone.6α-（碳-14）-甲基泼尼松龙的直肠吸收
Proc Soc Exp Biol Med. 1960 Jan;103:74-7.
6
Intrarectal treatment of 100 cases of ulcerative colitis with prednisolone-21-phosphate enemata.用磷酸泼尼松龙-21-磷酸盐灌肠剂直肠内治疗100例溃疡性结肠炎。
Br Med J. 1961 Jan 21;1(5220):165-8. doi: 10.1136/bmj.1.5220.165.
7
Studies on the absorption of hydrocortisone from the colon of patients with idiopathic ulcerative colitis.
Tex Rep Biol Med. 1958;16(4):508-14.
8
Rectal hydrocortisone.直肠用氢化可的松
Br Med J. 1957 Aug 3;2(5039):272-4. doi: 10.1136/bmj.2.5039.272.
9
Absorption of steroid hormones from the human small intestine.
J Clin Endocrinol Metab. 1965 Oct;25(10):1309-16. doi: 10.1210/jcem-25-10-1309.
10
On the absorption of prednisone and prednisolone disodium phosphate after rectal administration.关于泼尼松及泼尼松龙磷酸二钠经直肠给药后的吸收情况
Scand J Gastroenterol. 1969;4(7):582-4.
Zotero 插件